Intended for U.S. healthcare professionals only. For corporate information, please visit Mallinckrodt.com X
  • INTRAVENOUS PRODUCTS

    Mallinckrodt's pain management portfolio contains the first and only IV formulation of acetaminophen in the U.S. for patients in need of an intravenous analgesic for the management of pain.

    Our branded Intravenous Products portfolio includes:

    OFIRMEV® (acetaminophen) injection 100 mL vials, 1000 mg (10 mg/mL)

    INDICATIONS AND USAGE

    OFIRMEV (acetaminophen) injection is indicated for the management of mild to moderate pain, management of moderate to severe pain with adjunctive opioid analgesics, and reduction of fever.

    WARNING: RISK OF MEDICATION ERRORS AND HEPATOTOXICITY

    Take care when prescribing, preparing, and administering OFIRMEV Injection to avoid dosing errors which could result in accidental overdose and death. In particular, be careful to ensure that:

    • the dose in milligrams (mg) and milliliters (mL) is not confused;
    • the dosing is based on weight for patients under 50 kg;
    • infusion pumps are properly programmed; and
    • the total daily dose of acetaminophen from all sources does not exceed maximum daily limits.

    OFIRMEV contains acetaminophen. Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed the recommended maximum daily limits, and often involve more than one acetaminophen-containing product.

    Click “Learn More” for additional Important Risk Information including boxed warning and link to U.S. Full Prescribing Information. 
    Learn More